Related by context. All words. (Click for frequent words.) 77 oral prodrug 75 PDE4 inhibitor 75 ENMD # 75 liposomal formulation 74 metaglidasen 74 docetaxel Taxotere R 74 atacicept 74 IMA# 74 elotuzumab 74 teriflunomide 73 orally bioavailable 73 AEG# 73 JAK inhibitor 73 ganetespib 73 CCX# 73 HuMax EGFr 73 velafermin 73 RLY# 73 reslizumab 73 Factor Xa inhibitor 73 ADP receptor antagonist 73 pan HDAC inhibitor 73 Factor VIIa 73 oral Factor Xa 73 mertansine 72 Tyrima 72 CR# vcMMAE 72 SCH # 72 Phase 2a trial 72 evaluating tivozanib 72 PEG SN# 72 HuLuc# 72 vidofludimus 72 DU #b 72 Lixivaptan 72 alvespimycin 72 plasma kallikrein inhibitor 72 refractory gout 72 Bezielle 72 CCR9 antagonist 72 volociximab 71 pertuzumab 71 HQK 71 Carfilzomib 71 ATL# [002] 71 R#/MEM # 71 Pimavanserin 71 Panzem R 71 TBC# 71 sitaxsentan 71 MYDICAR ® 71 RGB # 71 GW# [003] 71 proteasome inhibitor 71 CBLC# 71 investigational humanized monoclonal antibody 71 Dasatinib 71 dexpramipexole 71 cannabinor 71 virus HCV protease inhibitor 71 elinogrel 71 INCB# [001] 71 Phase Ib study 71 TriRima 71 TG# [003] 71 Androxal TM 71 Sym# 71 Aflibercept 71 Plicera 71 PSN# [002] 71 Traficet EN 71 YONDELIS 71 CTAP# Capsules 71 Xanafide 70 systemically administered 70 preclinically 70 Panzem R NCD 70 Amigal 70 midstage clinical 70 cobiprostone 70 tezampanel 70 polymerase inhibitor 70 angiogenesis inhibitor 70 pomalidomide 70 Aliskiren 70 CIMZIA ™ 70 Mipomersen 70 highly selective inhibitor 70 Archexin 70 TRO# 70 forodesine 70 erlotinib Tarceva ® 70 Vidofludimus 70 cetuximab Erbitux R 70 ularitide 70 phase IIa clinical 70 intranasal formulation 70 dasatinib Sprycel ® 70 eniluracil 70 thalidomide Thalomid 70 MNTX 70 BRAF inhibitor 70 AAG geldanamycin analog 70 PSMA ADC 70 docetaxel Taxotere ® 70 phase IIb clinical 70 posaconazole 70 PNP inhibitor 70 PEGylated interferon beta 1a 70 Symadex 70 riociguat 70 ocrelizumab 70 XmAb# 70 pradefovir 70 CA4P 70 PRTX 70 CYT# potent vascular disrupting 70 small molecule tyrosine 70 OMP #M# 70 trodusquemine 70 HGS ETR1 70 TELINTRA 70 GLYX 70 investigational HCV polymerase 70 Vitaxin 70 Elotuzumab 70 ZOLINZA 70 canakinumab 70 HSP# inhibitor 70 oral antiviral 70 MAGE A3 ASCI 70 obatoclax 70 GRN# 70 bevacizumab Avastin ® 69 BAY #-# 69 lumiliximab 69 subcutaneous formulation 69 Aclidinium 69 Triolex 69 PKC# 69 inhaled formulation 69 receptor tyrosine kinase inhibitor 69 rNAPc2 69 indibulin 69 OncoVEX GM CSF 69 beta 1a 69 HGS# 69 mu opioid receptor antagonist 69 BAL# [002] 69 Azedra 69 antithrombotic 69 neratinib 69 phase IIb trial 69 Pazopanib 69 Clolar ® 69 dextromethorphan quinidine 69 enzastaurin 69 Degarelix 69 Omacetaxine 69 Naproxcinod 69 SAR# [004] 69 targeted radiotherapeutic 69 goserelin 69 Virulizin ® 69 VA# [002] 69 MGd 69 THR beta agonist 69 Nexavar sorafenib 69 nalbuphine ER 69 phase IIb 69 fosbretabulin 69 Phase Ib II 69 Zoraxel 69 anticancer compound 69 CIMZIA TM 69 eprotirome 69 baminercept 69 HGS ETR2 69 Dapagliflozin 69 favorable pharmacokinetic profile 69 CEQ# 69 lomitapide 69 otelixizumab 69 HuMax CD# 69 Phase IIb trials 69 radiation sensitizer 69 TPI ASM8 69 CDP# 69 Proxinium TM 69 selective androgen receptor modulator 69 anti amnesic 69 CoFactor 69 investigational monoclonal antibody 69 Fx #A 69 visilizumab 69 PEGylated Fab fragment 69 antiplatelet agent 69 incyclinide 69 TLK# 69 Tarceva TM 69 generation purine nucleoside 69 HuMax CD4 69 Alocrest 69 REG1 69 SinuNase ™ 69 APTIVUS 69 IMiDs ® 69 orally dosed 69 antibody MAb 69 XL# XL# 69 OHR/AVR# 69 octreotide acetate 69 nucleoside analog 69 peripherally acting 69 inhibitor RG# 69 urocortin 2 69 KRN# 69 Bicifadine 69 Glufosfamide 69 Ophena TM 69 CCX# B 69 NXL# 69 KNS # 69 ulimorelin 69 epothilones 69 sodium glucose cotransporter 69 bortezomib Velcade 68 telaprevir VX 68 TNF Tumor Necrosis Factor 68 Phase 1b trial 68 PROCHYMAL 68 reversible inhibitor 68 Amrubicin 68 Seliciclib 68 Talabostat 68 ALN PCS 68 PS# [001] 68 Annamycin 68 ALN TTR# 68 Cetrorelix 68 factor Xa inhibitor 68 AEGR 68 dihydrochloride 68 pegylated liposomal doxorubicin 68 aleglitazar 68 pharmacodynamic properties 68 ARIKACE ™ 68 direct thrombin inhibitors 68 selective agonist 68 ProSavin 68 Nanobody ® 68 HCV protease 68 HMG CoA reductase inhibitors 68 ocular formulation 68 Rigel R# 68 PEG Interferon lambda 68 depsipeptide 68 lesinurad 68 oxaliplatin Eloxatin 68 vascular disrupting agent 68 #I TM# 68 Asentar 68 ribavirin RBV 68 DAVANAT 68 HGS ETR1 mapatumumab 68 Phase #/#a 68 romidepsin 68 INTEGRILIN 68 PXD# 68 Onalta 68 pharmacokinetic PK study 68 mTOR inhibitor 68 mGluR5 NAM 68 Trofex TM 68 omega interferon 68 dasatinib Sprycel 68 Exelixis compounds 68 sunitinib Sutent ® 68 Pertuzumab 68 rhMBL 68 NVA# 68 alpha 2a 68 Nanobody 68 entinostat 68 PHX# 68 adecatumumab 68 Laquinimod 68 systemic RNAi therapeutic 68 selective antagonist 68 uric acid lowering 68 octreotide 68 gemcitabine Gemzar 68 Ambrisentan 68 Phase 1a clinical 68 Onconase 68 Inhalation Solution 68 Ophena 68 oral ridaforolimus 68 Panzem NCD 68 Azedra TM 68 Golimumab 68 seliciclib CYC# 68 prescribed proton pump 68 teduglutide 68 Bicalutamide 68 VAPRISOL 68 Amplimexon 68 Quinamed 68 Orally administered 68 Personalized Immunotherapy 68 histone deacetylase inhibitor 68 eltrombopag 68 EndoTAG TM -1 68 somatostatin analog 68 viral kinetics 68 mecamylamine 68 bendamustine 68 alkylating agent 68 SNT MC# 68 Panzem 68 betrixaban 68 Oral NKTR 68 multi kinase inhibitor 68 lucinactant 68 Meets Primary Endpoint 68 non nucleoside inhibitor 68 AQ4N 68 Shigamabs ® 68 adalimumab Humira 68 eritoran 68 Tezampanel 68 pharmacokinetic interactions 68 IRX 2 68 mapatumumab 68 Aurora kinase 68 ISF# 68 antitumor activity 68 BENICAR HCT 68 Vidaza azacitidine 68 cediranib 68 MEK inhibitor 68 desvenlafaxine succinate 68 ritonavir boosted 68 Zalypsis 68 subcutaneously administered 68 Velcade bortezomib 68 INT# [002] 68 ALN HPN 68 tezampanel NGX# 68 Squalamine 68 EXPAREL TM 68 Methylnaltrexone 68 NV1FGF 68 Boceprevir 68 sodium glucose transporter 68 ELACYT 68 LY# [003] 68 rHuPH# 68 ISIS # 68 apremilast 68 JAK inhibitors 68 CRMD# 68 tranilast 68 huC# DM4 67 Copegus ribavirin 67 PEG interferon 67 oxypurinol 67 relapsed MM 67 sunitinib malate 67 CRLX# 67 Apoptone 67 torezolid phosphate 67 Solulin 67 Neulasta ® 67 Zerenex 67 Targretin 67 Capesaris 67 Phase 2b study 67 MT#/MEDI-# 67 Interferon alpha 67 Lubiprostone 67 dacetuzumab 67 aflibercept VEGF Trap 67 GAMMAGARD 67 GMX# 67 albiglutide 67 corticosteroid dexamethasone 67 Desmoteplase 67 hyperphenylalaninemia HPA due 67 Fibrillex TM 67 lenalidomide dexamethasone 67 PEGylated anti 67 solithromycin 67 HCV protease inhibitors 67 Epratuzumab 67 nucleotide analog 67 sorafenib Nexavar 67 Cleviprex TM clevidipine 67 SPRYCEL ® 67 GVAX ® 67 imatinib Gleevec ® 67 salmeterol fluticasone 67 Aplidin 67 orally administered inhibitor 67 IAP inhibitor 67 candesartan cilexetil 67 renal toxicity 67 including eniluracil ADH 67 leading oral taxane 67 XOPENEX HFA 67 docetaxel Taxotere 67 huN# DM1 67 DXL# 67 Pegasys ® 67 long acting muscarinic 67 Vilazodone 67 FOLOTYN ® 67 Firazyr 67 OXi# 67 deforolimus 67 Nexavar ® 67 administered subcutaneously 67 MT# MEDI 67 Catena ® 67 ISTODAX 67 mitomycin 67 ketolide antibiotic 67 gemcitabine cisplatin 67 rilonacept 67 non nucleoside HCV 67 radezolid 67 lenalidomide Revlimid R 67 antitumor effects 67 DPP4 inhibitor 67 maximally tolerated dose 67 Adalimumab 67 vinca alkaloid 67 Azilect ® 67 P#X# antagonist 67 mitogen activated ERK kinase 67 Cethromycin 67 MEK inhibitors 67 DP b# 67 Telbivudine 67 SAR# [002] 67 mycophenolate mofetil 67 Varespladib 67 tocilizumab 67 MKC# MT 67 acetonide FA 67 neuroprotective properties 67 Kinoid 67 PI3K inhibitor 67 ACZ# 67 SinuNase TM 67 MKC# MKC# PP 67 rindopepimut 67 Cimzia TM 67 GLP toxicology studies 67 brivaracetam 67 axitinib 67 Cloretazine ® 67 methylnaltrexone bromide 67 Aptivus ® 67 hour bronchodilation 67 GLPG# 67 Angiocept 67 insulin sensitizer 67 Pemetrexed 67 ALGRX 67 Zybrestat 67 luliconazole 67 Tarceva erlotinib 67 delafloxacin 67 Safinamide 67 anti leukemic 67 immunomodulatory therapy 67 hormone LHRH antagonist 67 HspE7 67 novel histone deacetylase 67 paclitaxel Taxol ® 67 HCV protease inhibitor 67 histamine dihydrochloride 67 Panitumumab 67 darapladib 67 oral rivaroxaban 67 ancrod 67 brand ciclesonide HFA 67 MAP# 67 Menerba 67 GPIIb IIIa 67 molecular imaging radiopharmaceutical 67 Sapacitabine 67 PEGylated interferon 67 Silodosin 67 JVRS 67 hypoxia activated prodrug 67 trastuzumab DM1 T DM1 67 tigecycline 67 oral picoplatin 67 Dalbavancin 67 zileuton 67 Blinatumomab 67 GRNVAC1 67 Arikace 67 protein kinase inhibitor 67 LibiGel ® 67 PD LID 67 Tasimelteon 67 INCB# [002] 67 paclitaxel Taxol 67 Anavex #-# 67 iniparib 67 HCQ 67 midstage trials 67 opioid induced bowel dysfunction 67 Achieves Primary Endpoint 67 inhibitor PPI 67 PANVAC VF 67 Anthim 67 pharmacological chaperone 67 palonosetron 67 diabetic neuropathic pain 67 boosted protease inhibitor 67 lapatinib Tykerb 67 Chemophase 67 Perforomist ™ Inhalation Solution 67 RhuDex ® 67 MEK Inhibitor 67 ACTEMRA TM 67 GSK# [002] 67 Rebif ® 67 IMiD 67 Zorbtive TM 67 Icatibant 67 preclinical efficacy 67 relapsed multiple myeloma 67 LymphoStat B TM 67 irreversible inhibitor 67 immunomodulating 67 Doxil ® 67 danoprevir 67 5 Fluorouracil 67 personalized immunotherapy 67 Bortezomib 67 5 HT6 receptor 67 class mGluR5 inhibitor 67 alfa 2a 67 regorafenib 67 Navelbine ® 67 lipid lowering therapies 67 cidofovir 67 alpha 2b 67 selective adenosine 67 nab paclitaxel 67 Myelodysplastic Syndrome MDS 67 selective modulator 67 rxRNA 67 GFT# 67 tanespimycin 67 Insegia 67 phase IIb study 67 NOX E# 67 angiotensin receptor blocker ARB 66 Entereg R 66 Altastaph 66 DDP# 66 kidney urologic 66 Enzastaurin 66 IMiDs R 66 CYP#A# CYP#D# 66 SERMs 66 gefitinib Iressa 66 Dabigatran etexilate 66 Vicriviroc 66 NP2 Enkephalin 66 Cetuximab Erbitux 66 sorafenib tablets 66 histone deacetylase HDAC inhibitor 66 chemotherapy induced neutropenia 66 Pradefovir 66 Sudhir Agrawal D.Phil 66 micafungin 66 Arcalyst 66 Radezolid 66 edoxaban 66 bardoxolone methyl 66 somatostatin analogue 66 rFIXFc 66 mGluR2 NAM 66 methylnaltrexone 66 Campath ® 66 dextofisopam 66 lead Aganocide compound 66 CANCIDAS 66 LymphoStat B belimumab 66 #D#C# 66 herpetic keratitis 66 IGF 1R inhibitor 66 pegfilgrastim 66 Ocrelizumab 66 Daclizumab 66 glatiramer acetate 66 thymalfasin 66 AzaSite Plus 66 insulin sensitizing 66 EGFR TKI 66 BCX# 66 LHRH antagonists 66 ZK EPO 66 Zemiva TM 66 sargramostim 66 novel VDA molecule 66 protease inhibitor PI 66 Phase IIb clinical trials 66 GED aPC 66 Darusentan 66 mTOR inhibitors 66 MTP inhibitor 66 Zenvia ™ 66 invasive candidiasis 66 Proellex TM 66 talabostat 66 motesanib 66 Intravail ® 66 EXPAREL ™ 66 HDAC Inhibitor 66 CD3 monoclonal antibody 66 tafamidis 66 adenosine injection 66 cangrelor 66 alvimopan 66 tenofovir emtricitabine 66 vismodegib 66 nilotinib Tasigna 66 Xeloda ® 66 CG# [003] 66 PREOS R 66 cathepsin K inhibitor 66 Solazed TM 66 noninfectious uveitis 66 Phase Ib clinical 66 OvaRex R 66 Civacir 66 Candesartan 66 HCV NS5B polymerase 66 CD# CEA 66 EOquin TM 66 IV Busulfex 66 Thiarabine 66 Mg Usa 66 mGluR5 negative 66 ATL/TV# 66 Vaprisol 66 novel peptide 66 OvaRex ® MAb 66 Ecallantide 66 itraconazole Sporanox 66 Natalizumab 66 kinase inhibitor 66 leukemia AML 66 isoform selective 66 Elvitegravir 66 bicifadine 66 recurrent glioblastoma multiforme 66 vosaroxin 66 diarrhea predominant irritable 66 humanized anti 66 erlotinib Tarceva 66 GOUT 66 Phase IIb Trial 66 tipranavir 66 pegylated interferons 66 PDX pralatrexate 66 FOLFOX6 chemotherapy regimen 66 Phase 2b Clinical Trial 66 ruxolitinib 66 MoxDuo 66 proteasome inhibitor bortezomib 66 Fulvestrant 66 fostamatinib 66 Pegloticase 66 AeroLEF TM 66 atrasentan 66 trastuzumab Herceptin 66 Sugammadex 66 Pyridorin 66 confirmatory Phase III 66 Adlea 66 Synavive 66 RSD# 66 pan histone deacetylase 66 partial agonist 66 Reverset 66 novel oral anticoagulant 66 HCD# [002] 66 Hsp# Inhibitor 66 5 HT3 antagonist 66 Lu AA# 66 Liposomal 66 Ozarelix 66 PDE# inhibitors 66 APOPTONE 66 azilsartan medoxomil 66 Randomized Phase 66 AVN# [001] 66 AZILECT R 66 Alfimeprase 66 ongoing Phase 1b 66 RNAi therapeutic targeting 66 Luteinizing Hormone Releasing Hormone 66 Triapine 66 MEK inhibitor RDEA# 66 IPL# 66 JAK3 inhibitor 66 Fc fusion protein 66 tipifarnib 66 acyclovir Lauriad R 66 Romidepsin 66 intravenously administered 66 Aganocide 66 JAK1 66 catheter occlusion 66 ESBA# 66 Telatinib 66 rFVIIIFc 66 LAS# [002] 66 prucalopride 66 targeted antifolate 66 amrubicin 66 Phase III confirmatory 66 Eltrombopag 66 novel topoisomerase 66 Resten NG 66 renin inhibitor 66 perampanel 66 PTP 1B 66 aripiprazole Abilify 66 highly immunogenic 66 Soriatane 66 D aspartate NMDA receptor 66 ATL# [001] 66 PF # [001] 66 AMPK activators 66 Genentech Rituxan 66 anti emetic therapy 66 oral renin inhibitor 66 TORISEL 66 TO AVOID PREGNANCY WHILE 66 zalutumumab 66 Hsp# inhibitor 66 Cloretazine 66 dexanabinol 66 tivozanib 66 Pharmacokinetic studies 66 subcutaneous SC 66 ceftazidime 66 JAK2 inhibitor 66 INTEGRILIN ® 66 Lisofylline LSF 66 pharmacodynamic profile 66 Tesetaxel 66 ganaxolone 66 tyrosine kinase inhibitor 66 decitabine 66 Aurora kinase inhibitor 66 Liprotamase 66 RSD# oral 66 bardoxolone 66 humanized antibody 66 custirsen 66 oral FTY# 66 vinorelbine tartrate 66 xanthine oxidase inhibitor 66 Peginterferon alfa 2b 66 DEB# 66 HCV polymerase inhibitor 66 nitazoxanide 66 ara C 66 C1 INH 66 Ceflatonin R 66 CD# antibody [001] 66 SUTENT ® 66 Linaclotide 66 Syncria 66 Pegasys peginterferon alfa 2a 66 PEP# [003] 66 SYN# 66 CCR5 antagonist 66 varespladib 66 pharmacodynamic profiles 66 GLASSIA 66 Cand5 66 Maribavir 66 LEUKINE 66 ImmunoVEX HSV2 66 OMP #R# 66 Elagolix 66 TLR9 agonist 66 TRV# [001] 66 XL# anticancer compounds 66 OMNARIS Nasal Spray 66 platelet inhibitor 66 Cannabinor 66 cinacalcet 66 eosinophilic asthma 66 metastatic castration resistant 66 oral JAK1 66 CINQUIL 66 anticancer activity 66 Trandolapril 66 edifoligide 66 Neurodex 66 PEG uricase 66 CB2 selective receptor agonist 66 inhaled iloprost 66 Spiegelmer ® 66 oral proteasome inhibitor 66 Vandetanib 66 MYDICAR 66 antiangiogenic 66 BEMA Granisetron 66 ospemifene 66 Myocet 66 galiximab 66 Aloxi injection 66 MyVax R 66 paclitaxel poliglumex 66 vapreotide acetate 66 PEGPH# 66 Phase 2a clinical trials 66 XOMA 3AB 66 Leukine ® 66 Allovectin 7 66 epothilone 66 SMT C# 66 Lacosamide 66 Revlimid lenalidomide 66 Q#IR 66 Avanafil 65 candidate CRLX# 65 casopitant 65 pioglitazone HCl 65 PF # [002] 65 amikacin 65 talactoferrin 65 Peginterferon 65 Aplidin R 65 non peptidic protease 65 2 methoxyestradiol 65 Gleevec resistant 65 oral dihydropyrimidine dehydrogenase DPD 65 RECOTHROM R 65 dimebon latrepirdine 65 2A receptor agonist 65 DexaSite 65 Aurexis 65 oral anticoagulant 65 tolerability profiles 65 Febuxostat 65 biologic DMARD 65 trastuzumab Herceptin R 65 ILUVIEN ® 65 S/GSK# 65 Preclinical studies suggest 65 generation Hsp# inhibitor 65 oral taxane 65 CD# monoclonal antibody 65 AERx iDMS 65 6R BH4 65 TELCYTA 65 JAK Inhibitor 65 metastatic malignant 65 muraglitazar 65 trabectedin 65 Pharmacokinetics PK 65 treat dysmenorrhea 65 Thiovir 65 tyrosine kinase inhibitor TKI 65 HDL Mimetic Peptide 65 rEV# 65 aplindore 65 trastuzumab Herceptin ® 65 INCB# [003] 65 IAP inhibitors 65 Phase III Pivotal 65 ULORIC 65 verteporfin 65 Telintra 65 PCK# 65 Adentri 65 ONCONASE 65 busulfan 65 antithrombotics 65 Stedivaze 65 Cloretazine VNP#M 65 Levetiracetam 65 Temsirolimus 65 echinocandin 65 panitumumab Vectibix 65 KSP inhibitor 65 lexidronam injection 65 Ridaforolimus 65 SPC# [001] 65 Excellarate 65 Guanilib 65 investigational protease inhibitor 65 antifibrotic 65 generation antisense inhibitor 65 potent CYP#A# inhibitors 65 MoxDuo IR 65 Dacogen injection 65 TroVax ® 65 SinuNase 65 AZX# 65 IMiDs ® compound 65 viral kinetic 65 PEG PAL 65 Cancidas 65 CCR5 mAb 65 AZOR 65 mTOR inhibition 65 beta2 agonist 65 ibandronate 65 Protexia R 65 ALV# 65 Cloretazine R VNP#M 65 oral talactoferrin 65 Romiplostim 65 rALLy clinical trial 65 Relovair 65 phase IIa 65 ciclesonide 65 Alzhemed TM 65 Valdoxan 65 delta isoform 65 Indaflex TM 65 DermaVir Patch 65 deferiprone 65 pharmacologically active isomer 65 Presents Preclinical 65 DepoVax 65 Trofex 65 oral Xeloda 65 Vfend 65 rhITF 65 sapacitabine 65 Octreotide 65 TKM ApoB 65 LB# [003] 65 Genz # 65 AZILECT ® 65 CCR2 65 daclizumab 65 sodium thiosulfate STS 65 clevidipine 65 MLN# 65 PI3K/Akt pathway inhibitor 65 calcipotriene 65 Kahalalide F 65 R#/MEM 65 APTIVUS r 65 CorVue ™ 65 cMET 65 Tarvacin 65 TOLAMBA 65 Gattex 65 Vivecon 65 Initiates Phase II 65 LAF# 65 TYZEKA 65 Copegus ® 65 EGS# 65 multicenter Phase II 65 Epothilones 65 Troxatyl 65 CORT # 65 isatoribine 65 antitumor effect 65 targeting CD# 65 BRIM2 65 cisplatin gemcitabine 65 SLx 65 injectable formulation 65 oral salmon calcitonin 65 alpha blocker 65 hematological tumors 65 TOCOSOL Camptothecin 65 factor Xa 65 estramustine 65 Microplasmin 65 Kamada AAT 65 torezolid 65 AP# [003] 65 Xcytrin R 65 CYP #A# 65 certolizumab 65 TAFA# 65 chemopreventive agent